Skip to main content
Log in

PARP-1 and CASP3 genes are up-regulated in LNCaP and PC-3 prostate cancer cell lines

  • Letter to the Editor
  • Published:
Human Cell Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Steinberg GD, Carter BS, Beaty TH. Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate. 1990;17:337–47.

    Article  PubMed  CAS  Google Scholar 

  2. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5–26.

    Article  PubMed  Google Scholar 

  3. Trojan L, Kiknavelidze K, Knoll T, Alken P, Michel MS. Prostate cancer therapy: standard management, new options and experimental approaches. Anticancer Res. 2005;25:551–61.

    PubMed  Google Scholar 

  4. Kucuk O. Chemoprevention of prostate cancer. Cancer Metastasis Rev. 2002;21:111–24.

    Article  PubMed  CAS  Google Scholar 

  5. Gallagher RP, Fleshner N. Prostate cancer: 3. Individual risk factors. CMAJ. 1998;159:807–13.

    CAS  Google Scholar 

  6. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78–85.

    Article  PubMed  CAS  Google Scholar 

  7. Jemal A, Siegel, Ward E, Murray T, Xu J. and Thun M J. Cancer statistics CA. Cancer. J. Clin. 2007;57: 43–66.

  8. Walczak JR, Carducci MA. Prostate cancer: a practical approach to current management of recurrent disease. Mayo Clin Proc. 2007;82:243–9.

    Article  PubMed  Google Scholar 

  9. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S. Delineation of prognostic biomarkers in prostate cancer. Nature. 2001;412:822–6.

    Article  PubMed  CAS  Google Scholar 

  10. Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Death receptor-induced cell death in prostate cancer. J Cell Biochem. 2004;91:70–99.

    Article  PubMed  CAS  Google Scholar 

  11. Thornberry NA. Lazebnik Y. Caspases: enemies within. Science. 1998;281:1312–6.

    Article  PubMed  CAS  Google Scholar 

  12. Vela-Navarrete R, Escribano-Burgos M, Farré AL, García-Cardoso J, Manzarbeitia F, Carrasco C. Serenoa repens treatment modifies Bax/Bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia. Urology. 2005;173:507–10.

    Article  Google Scholar 

  13. Hassa PO, Hottiger MO. The diverse biological roles of mammalian PARPs, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci. 2008;13:3046–82.

    Article  PubMed  CAS  Google Scholar 

  14. Ossovskaya V, Koo IC, Kaldjian EP, Alvares C, Sherman BM. Up-regulation of poly(ADP-ribose) polymerase-1 (PARP1) in triple-negative breast cancer and other primary human tumor types. Genes Cancer. 2010;8:812–21.

    Article  Google Scholar 

  15. Cussenot O, Berthon P, Berger R, Mowszowicz I, Faille A. Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol. 1991;146:881–6.

    PubMed  CAS  Google Scholar 

  16. Berthon P, Cussenot O, Hopwood L, Leduc A, Maitland N. Functional expression of sv40 in normal human prostatic epithelial and fibroblastic cells—differentiation pattern of nontumorigenic cell-lines. Int J Oncol. 1995;6:333–43.

    PubMed  CAS  Google Scholar 

  17. Marcelli M, Cunningham GR, Haidacher SJ., Padayatty SJ, Sturgis L, Kagan C, Denner L. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res. 1998;58:76–83.

  18. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol. 1979;17:16–23.

    PubMed  CAS  Google Scholar 

  19. Calogero AE, Soma PF, Giuffrida MC, Giuffrida D, La Vignera S, Romano C, Castiglione R, Bosco P, Salemi M. PARP1 and CASP3 gene expression in a patient with multiple head and neck squamous cell carcinoma and Parkinson disease. Hum Cell. 2013;26:44–6.

    Article  PubMed  Google Scholar 

  20. Ha HC, Snyder SH. Poly (ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA. 1999;96:13978–82.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  21. Kannan S, Fang W, Song G, Mullighan CG, Hammitt R, McMurray J. Notch/HES1-mediated PARP1 activation: a cell-type specific mechanism for tumor suppression. Blood. 2011;117: 2891-2900;85: 669–79.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michele Salemi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salemi, M., Condorelli, R.A., La Vignera, S. et al. PARP-1 and CASP3 genes are up-regulated in LNCaP and PC-3 prostate cancer cell lines. Human Cell 27, 172–175 (2014). https://doi.org/10.1007/s13577-013-0076-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13577-013-0076-5

Keywords

Navigation